Abstract
Patients with human immuno-deficiency virus (HIV)-infection have a high prevalence of abnormal bone metabolism and vitamin D deficiency. Vitamin D treatment has some benefit in patients with HIV infection. In this paper, we review the evidence for an association between vitamin D and HIV infection. Literature search was done from Medline. Genetic studies have provided the opportunity to determine which proteins link vitamin D to HIV pathology [i.e., the major histocompatibility complex class II molecules, vitamin D receptor, cytochrome P450, renin-angiotensin system, apolipoprotein E, liver X receptor, toll-like receptor, poly(ADP-ribosyl) polymerase-1, natural resistanceassociated macrophage protein 1, and the Sp1 promoter gene]. Vitamin D also exerts its effect on HIV through nongenomic factors, i.e., ultraviolet radiation exposure, matrix metalloproteinase, heme oxygenase-1, the prostaglandins, cyclooxygenase-2, and oxidative stress.
In conclusion, vitamin D may have a beneficial role in HIV. Calcitriol, 1α,25-dihydroxyvitamin D3 should be tested in HIV-infected population because of its active form of the vitamin D3 metabolite and modulates inflammatory cytokine expression. Further investigation with calcitriol in HIV is needed.
Keywords: Calcitriol, HIV, human immuno-deficiency virus, Vitamin D, infection, MHC, DRB1, VDR, AIDS, NRAMP1
Current HIV Research
Title:The Beneficial Role of Vitamin D in Human Immunodeficiency Virus Infection
Volume: 11 Issue: 1
Author(s): Khanh vinh quoc Luong and Lan Thi Hoang Nguyen
Affiliation:
Keywords: Calcitriol, HIV, human immuno-deficiency virus, Vitamin D, infection, MHC, DRB1, VDR, AIDS, NRAMP1
Abstract: Patients with human immuno-deficiency virus (HIV)-infection have a high prevalence of abnormal bone metabolism and vitamin D deficiency. Vitamin D treatment has some benefit in patients with HIV infection. In this paper, we review the evidence for an association between vitamin D and HIV infection. Literature search was done from Medline. Genetic studies have provided the opportunity to determine which proteins link vitamin D to HIV pathology [i.e., the major histocompatibility complex class II molecules, vitamin D receptor, cytochrome P450, renin-angiotensin system, apolipoprotein E, liver X receptor, toll-like receptor, poly(ADP-ribosyl) polymerase-1, natural resistanceassociated macrophage protein 1, and the Sp1 promoter gene]. Vitamin D also exerts its effect on HIV through nongenomic factors, i.e., ultraviolet radiation exposure, matrix metalloproteinase, heme oxygenase-1, the prostaglandins, cyclooxygenase-2, and oxidative stress.
In conclusion, vitamin D may have a beneficial role in HIV. Calcitriol, 1α,25-dihydroxyvitamin D3 should be tested in HIV-infected population because of its active form of the vitamin D3 metabolite and modulates inflammatory cytokine expression. Further investigation with calcitriol in HIV is needed.
Export Options
About this article
Cite this article as:
vinh quoc Luong Khanh and Thi Hoang Nguyen Lan, The Beneficial Role of Vitamin D in Human Immunodeficiency Virus Infection, Current HIV Research 2013; 11 (1) . https://dx.doi.org/10.2174/1570162X11311010009
DOI https://dx.doi.org/10.2174/1570162X11311010009 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
Management of HIV: Management of HIV: old challenges and new needs
The aim of this thematic issue is to provide the most recent updates regarding the effective management of HIV infection. Antiretroviral therapy (ART) has significantly decreased HIV-related mortality, leading to an enhancement in the quality of life and life expectancy for people living with HIV (PLWH). Despite the numerous advancements ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advances of Phenoxazines: Synthesis, Reactivity and Their Medicinal Applications
Current Medicinal Chemistry Salivary Genomics, Transcriptomics and Proteomics: The Emerging Concept of the Oral Ecosystem and their Use in the Early Diagnosis of Cancer and other Diseases
Current Genomics Transcriptionally Targeted Adenovirus Vectors
Current Gene Therapy Stem Cell-Based Immunomodulation in Type 1 Diabetes: Beyond the Regenerative Approach
Current Pharmaceutical Design Mechanisms of ERK1/2 Regulation by Seven-Transmembrane-Domain Receptors
Current Pharmaceutical Design mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems
Current Drug Targets A Fluoro Derivative of Embelin, as Potent B-RAF Inhibitor in Melanoma
Anti-Cancer Agents in Medicinal Chemistry Pharmacokinetics and Pharmacodynamics of Lipidic Nano-Particles in Cancer
Anti-Cancer Agents in Medicinal Chemistry Naphthyridines with Antiviral Activity - A Review
Medicinal Chemistry Pharmacogenetics of Oxazaphosphorines and its Clinical Implications
Current Pharmacogenomics Virus-Like Particles as Particulate Vaccines
Current HIV Research Extraction, Structure and Bioactivities of the Polysaccharides from Fructus corni
Recent Patents on Food, Nutrition & Agriculture Systematic Evaluation of Drug-Loaded Hydrogels for Application in Osteosarcoma Treatment
Current Pharmaceutical Biotechnology MicroRNAs: Newcomers into the ALS Picture
CNS & Neurological Disorders - Drug Targets Biomarkers, Critical Disease Pathways, Drug Targets, and Alternative Medicine in Male Breast Cancer
Current Drug Targets Activin Receptor-Like Kinase 1: a Novel Anti-angiogenesis Target from TGF-β Family
Mini-Reviews in Medicinal Chemistry High-Throughput Functional Genomic Methods to Analyze the Effects of Dietary Lipids
Current Pharmaceutical Biotechnology Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Cellular Targets and Mechanisms in the Cytotoxic Action of Non-biodegradable Engineered Nanoparticles
Current Drug Metabolism Targeting Matrix Metalloproteinases in Inflammatory Conditions
Current Drug Targets